Diabetes Education App for Type 2 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, participants in both study groups will continue their routine follow-up care with their primary care physicians, which suggests you may continue your current medications.
What data supports the effectiveness of the Diabetes Education App for Type 2 Diabetes treatment?
Research shows that using internet and technology-based tools for diabetes education can improve patient outcomes by providing personalized support and helping patients manage their condition more effectively. These tools allow patients to track their health data, receive timely feedback, and connect with healthcare providers and support networks, which can lead to better self-management and improved health outcomes.12345
Is the Diabetes Education App for Type 2 Diabetes safe for humans?
How does the Diabetes Education App for Type 2 Diabetes differ from other treatments?
The Diabetes Education App for Type 2 Diabetes is unique because it provides an interactive and educational platform for self-management, using a mobile or web application to help users learn about and manage their condition effectively. Unlike traditional treatments that may focus solely on medication, this app emphasizes education and self-efficacy, offering tools like quizzes and a diabetes dictionary to enhance users' understanding and control of their diabetes.610111213
What is the purpose of this trial?
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study.Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study.Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled.Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.
Research Team
Luis A Murillo, MD, MPH
Principal Investigator
Reading Hospital Tower Health
Eligibility Criteria
This trial is for adults over 18 with uncontrolled Type 2 Diabetes (HA1c >8.0) who are patients at the Family Healthcare Center, Reading Hospital Tower Health. It's not for pregnant individuals, incarcerated people, those without a smartphone, or anyone unable to consent.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the intervention arm use the diabetes education app for 6 months, while control arm participants continue routine care
Follow-up
Participants are monitored for changes in HA1C, blood pressure, BMI, and self-efficacy for diabetes management
Treatment Details
Interventions
- Diabetes education web site application
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Reading Hospital and Medical Center
Lead Sponsor
Reading Hospital Foundation
Collaborator
Complete Statistical Services (Consult-Stat)
Collaborator